CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea
![CCDR](/content/dam/phac-aspc/images/services/reports-publications/canada-communicable-disease-report-ccdr/ccdr-wordmark1140.jpg)
![CCDR: Volume 45-2/3 February 7, 2019: Multidrug resistant gonorrhea](/content/dam/phac-aspc/images/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/45-23/ccdrv45i23-eng.jpg)
Published by: The Public Health Agency of Canada
Date published: February 7, 2019
ISSN: 1481-8531
Submit a manuscript
About CCDR
Browse
Table of contents
Surveillance
Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016
I Martin, P Sawatzky, V Allen, B Lefebvre, LMN Hoang, P Naidu, J Minion, P Van Caeseele, D Haldane, RR Gad, G Zahariadis, A Corriveau, G German, K Tomas, MR Mulvey
Public health insight
Addressing the rising rates of gonorrhea and drug-resistant gonorrhea: There is no time like the present
M Bodie, M Gale-Rowe, S Alexandre, U Auguste, K Tomas, I Martin
Commentary
The need for integrated public health surveillance to address sexually transmitted and blood-borne syndemics
M Murti, J Wong, M Whelan, C Renda, K Hohenadel, L Macdonald, D Parry
Surveillance
Tuberculosis in Canada: 2017
M LaFreniere, H Hussain, N He, M McGuire
Correction
Authors’ Correction: Can Commun Dis Rep 2018;44(12)
CCDR Editorial team
Search CCDR
Page details
- Date modified: